Trial reportEuropean journal of clinical nutrition2010
The metabolic fate of doubly labelled lactose-[13C, 15N]ureide after pre-dosing with different ureides.
Trial report in European journal of clinical nutrition, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Measurement of Oro-Cecal Transit Time in LPS-Treated Pigs Fed High and Low Fiber Diets Using the Lactose-Journal of agricultural and food chemistry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo date, the measurement of the orocaecal transit time (OCTT) with lactose-[(13)C]ureide usually requires a pre-dosing with the analogous substrate in its unlabelled form.
objectiveIn this study, the enzyme induction provoked by different unlabelled sugar ureides in OCTT measurements when using doubly labelled lactose-[(13)C, (15)N]ureide (DLLU) was evaluated.
methodsThirteen healthy adults (age: 22-58 years) received 500 mg DLLU together with a standardized breakfast. Expired air, urine and faeces were collected over a period of 14, 48 and 72 h, respectively. After 1 and 2 weeks, the test was repeated after pre-dosing of 3 x 120 mg glucose ureide (GU) and 3 x 200 mg cellobiose ureide (CU), respectively, on the day before study begin. The (13)C- and (15)N-enrichments were measured by isotope ratio mass spectrometry. The OCTT was calculated by the detection of a significant (13)CO(2) increase.
resultsIn comparison with the period without pre-dosing (7.8+/-2.2 h), the measured OCTT was significantly lowered either after GU pre-dosing (5.8+/-1.9 h, P=0.033) or CU pre-dosing (6.0+/-2.2 h, P=0.039). The respective renal (13)C- and (15)N-excretions amounted to 24.5 and 45.6, 24.7 and 54.0, and 22.5 and 50.1%, respectively, whereas the faecal (13)C- and (15)N-excretions amounted to 12.1 and 45.8, 4.8 and 21.5, and 9.6 and 39.8%, respectively.
conclusionsPre-dosing with unlabelled GU and CU before the administration of DLLU led to an unequivocal induction of the enzyme activity and resulted in a definitive estimation of the OCTT, clearly demonstrating that glucose-[(13)C]ureide is the matrix of the bacterial degradation in the caecum.
Indexed as
Identifiers
20485302What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.